Akoya Biosciences Inc (NAS:AKYA)
$ 2.45 -0.1 (-3.92%) Market Cap: 126.39 Mil Enterprise Value: 165.50 Mil PE Ratio: 0 PB Ratio: 9.11 GF Score: 46/100

Akoya Biosciences Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 11:45PM GMT
Release Date Price: $5.08 (+0.99%)
Rachel Vatnsdal JPMorgan Chase;Co.;Analyst

&-

Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team at JPMorgan. I'm joined today with the Akoya Biosciences management team up here. And so if any of you in the room do have questions, please feel free to send them to me directly or you can submit them via portal. With that, I will ask Brian to kick us off with the presentation.

Brian McKelligon
Akoya Biosciences Inc - President, Chief Executive Officer, Director

Thank you, Rachel. On behalf of all my colleagues at Akoya, thanks to you and your team at JPMorgan for having us. So again, I'm Brian McKelligon, the CEO of Akoya. Maybe just before I get started, I think Akoya, I think we're both proud and humbled by the journey over the last five or six years. Proud in that we've taken a handful of people and this idea of spatial biology and turned it into a company that's going to deliver just under $100 million this year. But really humbled because we feel like we have some distance to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot